MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-06-0044756
Glorax Pharmaceutical Private Limited
Glorax Pharmaceutical Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹37.19 Lakh
▲ 16% YoY
Net profit · FY 2025
₹42,607
Net margin 1.1%
EBITDA · FY 2025
₹67,445
EBITDA margin 1.8%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Glorax Pharmaceutical Private Limited
Data last updated:
Glorax Pharmaceutical Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 September 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2017PTC324073. Its GSTIN is 07AAHCG0185A1Z1 (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajesh Kumar and Gaurav Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat C6 Plot 39/3 Kh88/1 Back Rightportion 1st Floor Blk – Gvijay Vihar Rohini Phase 2, New Delhi, Delhi, India – 110085.
As per the financials filed for FY 2025, the company reported a revenue of ₹37.19 Lakh, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹42,607 (net margin 1.1%) and EBITDA of ₹67,445 (EBITDA margin 1.8%). Revenue has grown at a compounded annual rate (CAGR) of 80% over three years and 33% over five years.
Glorax Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0044756). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74999DL2017PTC324073
Registration Number 324073
Incorporation Date 25 September 2017
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-06-0044756
Key People
Rajesh Kumar Director Gaurav Kumar Director Recognitions & Rankings of Glorax Pharmaceutical
Contact details
Glorax Pharmaceutical Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressFlat C6 Plot 39/3 Kh88/1 Back Rightportion 1st Floor Blk – Gvijay Vihar Rohini Phase 2, New Delhi, Delhi, India – 110085
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Glorax Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Glorax Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Glorax Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Glorax Pharmaceutical Private Limited, buy the company report.
Financials of Glorax Pharmaceutical Private Limited
FY 2025 filings availableGlorax Pharmaceutical Private Limited reported revenue of ₹37.19 Lakh (up 16% YoY) for FY 2025.
Revenue · FY 2025
₹37.19 Lakh ▲ 16%
Net profit · FY 2025
₹42,607 margin 1.1%
EBITDA · FY 2025
₹67,445 margin 1.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 16%
3 years · compounded
▲ 80%
5 years · compounded
▲ 33%
EBITDA CAGR growth
1 year
▲ 64%
3 years · compounded
▲ 74%
5 years · compounded
▲ 44%
Revenue has grown at a compounded annual rate (CAGR) of 33% over five years, including 16% growth in the latest year. EBITDA rose 64% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹67,445 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹42,607 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.8% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Glorax Pharmaceutical Private Limited, buy the company report.
Board of directors of Glorax Pharmaceutical Private Limited
Glorax Pharmaceutical has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Kumar | Director | 25 Sep 2017 | 9 Years 1 Months | Current |
| Gaurav Kumar | Director | 25 Sep 2017 | 9 Years 1 Months | Current |
Peer comparison
Glorax Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| SRNC Bodycare Private Limited | ₹37.34 Lakh (FY 2025) | -92.0% | Kolkata, West Bengal, India | |||
| Aimglobal Mart Private Limited | ₹37.34 Lakh (FY 2025) | Kolkata, West Bengal, India | ||||
| Kamrupa Gold Buyers (OPC) Private Limited | ₹37.32 Lakh (FY 2025) | 450.0% | Gmc, Assam, India | |||
| Kuv Life Care Private Limited | ₹37.31 Lakh (FY 2024) | 2.0% | New Delhi, Delhi, India | |||
| Blumburg Packaging India Private Limited | ₹37.24 Lakh (FY 2025) | -8.0% | Ranchi, Jharkhand, India | |||
| Glorax Pharmaceutical Private Limitedthis company | ₹37.19 Lakh (FY 2025) | ₹42,607 | 1.1% | 16.0% | New Delhi, Delhi, India | |
| Nucleus Meditech Private Limited | ₹37.14 Lakh (FY 2025) | 253.0% | New Delhi, Delhi, India | |||
| Opb Fibre Products Manufacturing Private Limited | ₹37.14 Lakh (FY 2025) | 15.0% | Kolkata, West Bengal, India | |||
| Revik Industries and Technologies Private Limited | ₹37.12 Lakh (FY 2025) | 10.0% | Poovanthuruthu Po, Kerala, India | |||
| Niveda Management Services Private Limited | ₹37.1 Lakh (FY 2025) | 49.0% | New Delhi, Delhi, India | |||
| United Agencies(Bombay) Private Limited | ₹37.06 Lakh (FY 2025) | -32.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Glorax Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Glorax Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Glorax Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Glorax Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAHCG0185A1Z1 | Delhi | Active | 14 Dec 2017 |
To see the full GST registrations and return filing status of Glorax Pharmaceutical Private Limited, buy the company report.
Recent activity
Glorax Pharmaceutical Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Gaurav Kumar was appointed as Director on 25 Sep 2017.
AGM
Glorax Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Glorax Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Appointed
Gaurav Kumar was appointed as Director.
Appointed
Rajesh Kumar was appointed as Director.
Incorporation
25 Sep 2017
Glorax Pharmaceutical Private Limited was registered on 25 Sep 2017 with Roc Delhi Ii & aged 9 years 1 month as per MCA records.
Frequently asked questions
Glorax Pharmaceutical is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 September 2017 (9+ years old) and is registered under CIN U74999DL2017PTC324073.
Glorax Pharmaceutical has 2 current directors:
- Rajesh Kumar - Director
- Gaurav Kumar - Director
The latest financial statements of Glorax Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Glorax Pharmaceutical is 07AAHCG0185A1Z1, registered in Delhi.
The CIN (Corporate Identification Number) of Glorax Pharmaceutical is U74999DL2017PTC324073. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Glorax Pharmaceutical was incorporated on 25 September 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Glorax Pharmaceutical by revenue are SRNC Bodycare Private Limited, Aimglobal Mart Private Limited, Kamrupa Gold Buyers (OPC) Private Limited, Kuv Life Care Private Limited, Blumburg Packaging India Private Limited and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Gaurav Kumar was appointed as Director on 25 Sep 2017. Rajesh Kumar was appointed as Director on 25 Sep 2017.
Yes, Glorax Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-06-0044756).
The registered office of Glorax Pharmaceutical is at Flat C6 Plot 393 Kh881 Back Rightportion 1st Floor Blk – Gvijay Vihar Rohini Phase 2, New Delhi, Delhi, India – 110085.
Glorax Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.